European Archives - Page 80 of 1209 - European Medical Journal

Could Severe Atopic Dermatitis Increase Heart Disease Risk?

Pure atopic dermatitis patients had a significantly higher prevalence of cardiovascular disease compared to those with atopic comorbidities

EMJ Dermatology 13 [Supplement 2] 2025

A chronic, relapsing, inflammatory skin condition, atopic dermatitis (AD) is associated with a high disease burden that affects patients…

Transforming MS Care: Early Intervention and Sustained Safety

The video presents a satellite symposium titled ‘Transforming MS Care: Early Intervention and Sustained Safety’ held at the 40th…

Tralokinumab – Updates in Atopic Dermatitis

Atopic dermatitis (AD) is a chronic, relapsing, inflammatory skin condition, associated with a high disease burden that affects patients…

New Prostate Cancer Risk Gene Identified

The investigation began with a comparison between 3,716 PCa patients from Johns Hopkins University, Baltimore, Maryland.

The word spotlight on a blue background

Spotlight: May 2025

Catch up on May’s key pharma news, research updates and policy shifts.

Innovator, Author, and Leader: Interview with Srihari S. Naidu

EMJ spoke with Srihari S. Naidu, who shared insights into his pioneering work in alcohol septal ablation, his contributions as a published…

DBT Outperforms Mammography for Breast Cancer Screening in High-Risk Women

Study shows DBT improves breast cancer screening outcomes in high-risk women, particularly those with dense breast tissue.

Experimental Drug Shows Hopeful Results in Aggressive ALS

Experimental drug jacifusen shows promise for rare ALS, with some patients experiencing unprecedented recovery and stabilisation.

Bradley Monk

Onc Now: Episode 18: What's New from ESGO 2025?

Bradley Monk, Medical Director of Late-Phase Research at Florida Cancer Specialists, shares his insights from ESGO 2025 and landmark studies in gynaecologic oncology.